The latest news and exclusive analysis across the FDA-regulated industries from former FDA professionals and industry experts. New issues every month. Save time gathering the critical industry intelligence you need to act on.
Platform | Substack | Pricing | Freemium | Publishes | Daily |
---|---|---|---|---|---|
Issues | 174 | Subscribers | Read | insider.thefdagroup.com |
Curious about how many subscribers The FDA Group's Insider Newsletter has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over one million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Recent posts by this newsletter. Browse the email archive.
A few years back, we sat down with former FDA Investigator and current consultant Chris Smith to discuss how FDA plans and conducts its PAIs — and how industry teams can effectively prepare for them.
The FDA’s final guidance on DCTs adds clarity on HCP task log, inspection requirements, and data variability. We break it down.
Here's what's happening at FDA and across the broader life science RA/QA space.
The FDA 510(k) submission process is complex and can be challenging for companies, especially those unfamiliar with the regulatory requirements. Over the many years we've spent helping device firms gain market clearance through this pathway...
Other publications recommended by the authors of this newsletter.
The writers behind this newsletter.
The FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates.
You can find recent issues that have been published by The FDA Group's Insider Newsletter on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to The FDA Group's Insider Newsletter, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch The FDA Group's Insider Newsletter as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact The FDA Group's Insider Newsletter using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Similar Newsletters to see other publications like The FDA Group's Insider Newsletter. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.